It appears that Medtronic continues to run afoul with the FDA.  They received this FDA warning letter in Jan. 2022.  Medtronic was late issuing a recall on the MiniMed insulin pump after the FDA had received more than 57,000 medical device reports (MAUDE) over the previous three years.



No responses yet

Leave a Reply